0001835022 2026-03-29 2026-03-29 true 0001835022 8-K/A 2026-03-29 Coya Therapeutics, Inc. DE 001-41583 85-4017781 5850 San Felipe St. Suite 500 Houston TX 77057 (800) 587-8170 false false false false Common Stock, par value $0.0001 per share COYA NASDAQ true false This Amendment No. 1 to Current Report on Form 8-K/A (the “Amendment”) amends the Current Report on Form 8-K of Coya Therapeutics, Inc. (the “Company”) dated March 29, 2026 and filed with the Securities and Exchange Commission on April 2, 2026 (the “Original Form 8-K”), which disclosed the appointment of Mark H. Pavao to the Board of Directors of the Company (the “Board”), effective April 1, 2026. At the time of filing the Original Form 8-K, no determination had been made with respect to the appointment of Mr. Pavao to any committees of the Board.